HKUMed has achieved a significant breakthrough in developing needle-free, live-attenuated influenza vaccines with broad protection against human and avian virus subtypes.

The isolation of influenza virus 80 years ago in 1933 very quickly led to the development of the first generation of live-attenuated vaccines. The first inactivated influenza vaccine was ...

A recombinant flu vaccine (Flublok) contains no eggs and was recently approved for use in individuals aged 9 years or older ...

Shedding is common after receiving a live attenuated influenza vaccine, according to the CDC, especially among younger people. Shedding is not the same as transmission, since transmission requires ...

It's expected to be available next year. FluMist itself is not new — the live attenuated influenza vaccine has had FDA approval for more than two decades.

A new, two-step flu vaccination strategy that pairs intramuscular injection of a viral vectored flu vaccine with nasal spray administration of a novel attenuated live flu virus appears to be safe ...

Most flu vaccines contain inactivated influenza viruses, but there is one that contains a live weakened virus. Learn more about flu vaccines here.

These virus types are responsible for most flu infections in humans. FluMist is a live, attenuated vaccine, meaning it contains weakened versions of influenza A and B viruses.

Live-attenuated influenza vaccines can be administered through the nose directly into the upper respiratory tract, prompting a multi-pronged immune response against infection.

Novel, needle-free, live-attenuated influenza vaccines with broad protection against human and avian virus subtypes Date: May 9, 2025 Source: The University of Hong Kong Summary: A research team ...

HKUMed has achieved a significant breakthrough in developing needle-free, live-attenuated influenza vaccines with broad protection against human and avian virus subtypes.

These virus types are responsible for most flu infections in humans. FluMist is a live, attenuated vaccine, meaning it contains weakened versions of influenza A and B viruses.